Industry forum: Progress in pursuit of therapeutic A2A antagonists: The adenosine A2A receptor selective antagonist KW6002: Research and development toward a novel nondopaminergic therapy for Parkinson's disease

H. Kase , S Aoyama , M Ichimura , K Ikeda , A Ishii , T Kanda , K Koga , N Koike , M Kurokawa , Y Kuwana , A Mori , J Nakamura , H Nonaka , M Ochi , M Saki , J Shimada , T Shindou , S Shiozaki , F Suzuki , M Takeda , K Yanagawa , P Richardson , P Jenner , P Bedard , Emiliana Borrelli (1) , R Hauser , T Chase

1 IGBMC - Institut de génétique et biologie moléculaire et cellulaire

Domaines: Neurosciences [q-bio.NC]

H. Kase, S Aoyama, M Ichimura, K Ikeda, A Ishii, et al.. Industry forum: Progress in pursuit of therapeutic A2A antagonists: The adenosine A2A receptor selective antagonist KW6002: Research and development toward a novel nondopaminergic therapy for Parkinson's disease. Neurology, 2003, 61 (Issue 11, Supplement 6), pp.S97-S100. ⟨10.1212/01.wnl.0000095219.22086.31⟩. ⟨hal-04145245⟩